𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Women's experiences with genomic testing for breast cancer recurrence risk

✍ Scribed by Janice P. Tzeng; Deborah Mayer; Alice R. Richman; Isaac Lipkus; Paul K. Han; Carmina G. Valle; Lisa A. Carey; Noel T. Brewer

Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
171 KB
Volume
116
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Risk for breast cancer among women with
Risk for breast cancer among women with endometriosis
✍ Lisbeth Bertelsen; Lene MellemkjΓ¦r; Kirsten Frederiksen; Susanne K KjΓ¦r; Louise πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 French βš– 80 KB πŸ‘ 2 views

## Abstract Although several risk factors are common to endometriosis and breast cancer, the results of observational studies of an association have so far been inconsistent. We evaluated the relationship between endometriosis and breast cancer on the basis of data on selected cancers and medical h

Eating pathology and obesity in women at
Eating pathology and obesity in women at risk for breast cancer recurrence
✍ Rock, Cheryl L. ;McEligot, Archana J. ;Flatt, Shirley W. ;Sobo, Elisa J. ;Wilfle πŸ“‚ Article πŸ“… 2000 πŸ› Wiley (John Wiley & Sons) 🌐 English βš– 157 KB πŸ‘ 2 views

Objective: This cross-sectional study investigated the relationship among obesity, depressive symptoms, eating attitudes and behaviors, and dietary intake. It compared women at risk for recurrence of breast cancer and women who had not been diagnosed with breast cancer and were recruited from the sa

Risk of early recurrence among postmenop
Risk of early recurrence among postmenopausal women with estrogen receptor-positive early breast cancer treated with adjuvant tamoxifen
✍ Hagen Kennecke; Heather McArthur; Ivo A. Olivotto; Caroline Speers; Chris Bajdik πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 162 KB πŸ‘ 1 views

## Abstract ## BACKGROUND Adjuvant aromatase inhibitors (AIs), instead of or after tamoxifen, are effective in decreasing recurrence in postmenopausal women with estrogen receptor (ER)‐positive breast cancer. An understanding of which patients are at risk of early recurrence while they are receivi